Lefkofsky: Generative AI is more impactful in healthcare diagnostics
Eric Lefkofsky, founder and CEO of Tempest AI, explains the impact of acquiring Ambry, a genetic testing company, which ...
Modern Healthcare3h
AI isn't showing ROI—yet. Here's where there's promise.
Experts say Investors may be valuing AI companies too generously if health systems can’t justify the costs of these tools.
24/7 Wall St1d
Why Tempus AI (TEM) Is Soaring Today
Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...
Tempus Completes Acquisition of Ambry Genetics
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Tempus AI shares rise 5% pre-market on continued momentum, Ambry Genetics acquisition
Shares of Tempus AI , Inc. (NASDAQ:TEM) climbed 5% in pre-open trading Tuesday following the completion of its acquisition of ...
Why Tempus AI Inc. (TEM) Soared on Monday
We recently compiled a list of the 10 Firms Shine Amid Market Slump. In this article, we are going to take a look at where ...
Top 10 AI Stocks Trending On Wall Street
The tech world may be steering in a new direction with the emergence of DeepSeek and the cheaper and more efficient models it ...
New York Post5d
Eric Bieniemy coming back to NFL to join Bears’ coaching staff
Eric Bieniemy is headed to the Windy City. The Bears hired Bieneimy as their running backs coach, bringing the former NFL offensive coordinator back to the league, according to multiple reports ...
Ars Technica4d
Eric Berger
Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars ...